Bausch Health Companies Inc. (BHC) — SEC Financial Statements & Analysis

Bausch Health Companies Inc. (BHC) is a pharmaceutical preparations company, incorporated in NJ. Bausch Health Companies Inc. trades on NYSE as: BHC. Bausch Health Companies Inc. (BHC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-30. Based on that filing, Bausch Health Companies Inc. carries a market cap of $1.85B, a P/E ratio of -1.69x, a P/B ratio of -2.31x, a P/S ratio of 0.17x, an enterprise value of $20.75B, and an EV/EBITDA multiple of 10.10x. On profitability, it posts a gross margin of 72.43%, an operating margin of 8.14%, a net margin of -10.07%, a Return on Equity (ROE) of 333.74%, a Return on Assets (ROA) of -4.20%, and a Return on Invested Capital (ROIC) of 4.57%. Per share, it reports EPS of $-2.91, diluted EPS of $-2.89, free cash flow per share of $3.82, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 10.09% year-over-year, net income growth of -1891.80% year-over-year, and EPS growth of -1872.21% year-over-year. On the balance sheet, it maintains a current ratio of 1.44x, a quick ratio of 0.90x, working capital of $1.98B, a debt-to-equity ratio of -31.92x, a debt ratio of 1.03, an interest coverage ratio of 0.55x, free cash flow of $1.43B (TTM), and net debt of $18.90B. Figures sourced from SEC EDGAR.

Market Cap

$1.85B

P/E TTM

-1.69x

EPS TTM

$-2.91

P/B TTM

-2.31x

ROE TTM

333.74%

ROA TTM

-4.20%

Debt To Equity

-31.92x

Free Cash Flow TTM

$1.43B

Net Revenue TTM Growth 1Y

10.09%

Data as of 2026-06-30 · Source: SEC EDGAR